Bimatoprost is a medication used to treat high pressure inside the eye including glaucoma.Specifically it is used for open angle glaucoma when other agents are not sufficient.It may also be used to increase the size of the eyelashes. It is used as an eye drop.
This report contains market size and forecasts of Latisse (Bimatoprost) ( CAS 155206-00-1) in global, including the following market information:
Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Latisse (Bimatoprost) ( CAS 155206-00-1) companies in 2021 (%)
The global Latisse (Bimatoprost) ( CAS 155206-00-1) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medicine Grade Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Latisse (Bimatoprost) ( CAS 155206-00-1) include Allergan plc (AbbVie Inc.), Sandoz(Novartis), Hi-Tech Pharmacal and Apotex Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Latisse (Bimatoprost) ( CAS 155206-00-1) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Segment Percentages, by Type, 2021 (%)
Medicine Grade
Cosmetic Grade
Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Segment Percentages, by Application, 2021 (%)
Medicine
Cosmetic
Others
Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Latisse (Bimatoprost) ( CAS 155206-00-1) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Latisse (Bimatoprost) ( CAS 155206-00-1) revenues share in global market, 2021 (%)
Key companies Latisse (Bimatoprost) ( CAS 155206-00-1) sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Latisse (Bimatoprost) ( CAS 155206-00-1) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan plc (AbbVie Inc.)
Sandoz(Novartis)
Hi-Tech Pharmacal
Apotex Inc.